Change in Management

July 29, 2026 The Department of Corporate Services- Listing The Department of Corporate Services- Listing BSE Ltd, National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street Bandra Kurla Complex, Mumbai-400 001 Bandra (E) Mumbai – 400 051 Scrip Code: 507789 Symbol: JAGSNPHARM Subject: Change in Senior Management Personnel of the Company - Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Dear Sir/ Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Part A of Schedule III thereto, we wish to inform that consequent to internal restructuring the following individuals have been designated as Senior Management Personnel of the Company effective July 29, 2026: 1. Mr. Balmukund Keshav, Deputy General Manager (Information Technology). 2. Mr. Sanjay Singhal, General Manager- (CQA & Regulatory Affairs). Details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 are enclosed as Annexure A. We request you to take the above on record. Thanking you, For Jagsonpal Pharmaceuticals Limited Pratham Rawal Company Secretary & Compliance officer Annexure-A Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule Ill of the Listing Regulations read with SEBI master circular HO/49/14/14(7)2025-CFD-POD2/l/3762/2026 dated January 30, 2026 related to appointment as mentioned below: S. Particulars Mr. Balmukund Keshav Mr. Sanjay Singhal No. DGM – (Information Technology) General Manager (CQA & Regulatory Affairs) 1. Reason for Change viz Designated as Senior Management Designated as Senior Management Personnel. appointment, Personnel re-appointment, resignation, removal, death or otherwise; 2. Date of appointment 29th July, 2026 29th July, 2026 Cessation & term of appointment Term of Appointment:- Term of Appointment:- Not Applicable Not Applicable 3. Brief Profile Mr. Balmukund Keshav holds an MBA in Sanjay Singhal is a Pharmacy professional Information Systems from Sikkim Manipal with Masters Degree in Pharmaceutical University and a B.Sc. (Chemistry Hons.) science from Birla Institute of Technical from Magadh University. studies, Pilani (BITS PILANI). He has over 29 years of experience in IT Mr. Sanjay Singhal has 31 years’ experience leadership and currently serves as Deputy in pharmaceutical industry, with General Manager – IT at Jagsonpal comprehensive expertise across the entire Pharmaceuticals Ltd. all pharmaceutical divisions including manufacturing, supply chain, Quality and During his 17-year tenure with Jagsonpal, regulatory affairs. he has led digital transformation, ERP implementation, ITGC audits, and He has been associated with the Company enterprise infrastructure management. since 11 March, 2020. His expertise includes IT governance, risk and information security, vendor Mr. Sanjay Singhal is also Government management, and digital process approved technical person for all dosage automation. forms across manufacturing and analytical divisions. 4. Disclosure of relationships Not Applicable Not Applicable between Directors (In case of appointment of Director) 5. Information as required Not Applicable Not Applicable pursuant to BSE Circular with ref. no. LIST/ COMP/ 14/2018- 19 and the National Stock Exchange of India Ltd with ref. no. NSE/ CML/2018/24, both dated June 20, 2018.